quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:09:48·62d
SECFiling
Virtu Financial Inc. logo

SEC Form 10-K filed by Virtu Financial Inc.

VIRT· Virtu Financial Inc.
Finance
Full content unavailable. See the original source below.
Original source

Companies

  • VIRT
    Virtu Financial Inc.
    Finance

Recent analyst ratings

  • Oct 28UpdateBofA Securities$45.00
  • May 15UpdateBofA Securities$43.00
  • Apr 8UpdateMorgan Stanley$26.00
  • Nov 28UpdateBofA Securities$20.00
  • Sep 14UpdateCitigroup$20.00
  • Apr 11UpdateMorgan Stanley$21.00

Related

  • PR16d
    Virtu Financial to Host Conference Call Announcing First Quarter 2026 Results on Wednesday, April 29, 2026
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Virtu Financial Inc.
  • PR32d
    Nissay Asset Management Adopts Triton
  • INSIDER62d
    Co-President & Co-COO Molluso Joseph sold $7,776,420 worth of shares (200,000 units at $38.88), decreasing direct ownership by 38% to 326,585 units (SEC Form 4)
  • INSIDER64d
    EVP Cavoli Stephen sold $1,104,657 worth of shares (28,370 units at $38.94), decreasing direct ownership by 20% to 116,191 units (SEC Form 4)
  • INSIDER69d
    EVP Cavoli Stephen sold $2,728,560 worth of shares (71,630 units at $38.09), decreasing direct ownership by 33% to 144,561 units (SEC Form 4)
  • INSIDER76d
    Chief Financial Officer Lee Cindy converted options into 13,672 shares, covered exercise/tax liability with 9,635 shares and was granted 5,523 shares, increasing direct ownership by 43% to 31,637 units (SEC Form 4)
  • INSIDER76d
    Amendment: Chief Financial Officer Lee Cindy was granted 2,343 shares and covered exercise/tax liability with 1,296 shares, increasing direct ownership by 8% to 13,377 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022